483
Maria E. De La Torre Silva, MDFDA 483 - Maria E. De La Torre Silva, MD - July 15, 2025
Record Details
An FDA inspection of West Palm Quality Research, a clinical investigator in West Palm Beach, FL, revealed significant deficiencies in the conduct of clinical trials. The firm failed to adhere to investigational plans, including not conducting a protocol, enrolling subjects who met exclusion criteria, and administering expired investigational product. Additionally, the firm failed to maintain accurate case histories, with discrepancies noted between dispensed and returned investigational products.
Open in Dashboard
ID · b5291641-216e-44e0-80c5-711b684de74c